Jamie Mihoko Doyle, Ph.D.
Program Director
Clinical and Translational Science Awards Program Branch
Division of Clinical Innovation
Digital & Mobile Technologies Section
Contact Info
Biography
Jamie Mihoko Doyle is a program director in the Digital & Mobile Technologies Section of the Clinical and Translational Science Awards (CTSA) Program Branch within NCATS' Division of Clinical Innovation, where she manages a portfolio of CTSA Program grants. Prior to joining NCATS, Doyle was a team lead in the Division of Statistical Analysis and Reporting within the NIH Office of Extramural Research (OER), where she led analyses supporting trans-NIH programmatic activities, policy development and workforce planning. Prior to her tenure at OER, she was a program evaluator at the Health Resources and Services Administration, in the Bureau of Health Workforce, where she led the design, restructuring and evaluation of primary health care training programs. Doyle also has held regulatory and science policy positions at the National Institute of Mental Health, the Science and Technology Policy Institute, and Pfizer, Inc.
Doyle earned her doctorate in demography from the University of Pennsylvania and holds a Bachelor’s degree in economics from the University of Texas at Austin. She completed her postdoctoral training in epidemiology at the Perelman School of Medicine at the University of Pennsylvania, where she examined social and environmental factors associated with injury and mortality risk in Guatemala and among Hispanics in Philadelphia.
Research Topics
Doyle has a continued interest in topics related to early career researchers, biomedical research workforce diversity and science policy.
Selected Publications
-
Association of Percentile Ranking with Citation Impact and Productivity in a Large Cohort of De Novo NIMH-Funded R01 Grants
-
Associations of Topic-Specific Peer Review Outcomes and Institute and Center Award Rates with Funding Disparities at the National Institutes of Health
-
Downstream Funding Success of Early Career Researchers for Resubmitted Versus New Applications: A Matched Cohort
-
What Race and Ethnicity Measure in Pharmacologic Research